AI assistant
BOTANIX PHARMACEUTICALS LTD — Major Shareholding Notification 2022
Nov 9, 2022
64551_rns_2022-11-09_cd428ab4-8465-42fc-a285-54e93e890eee.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder
| To : | BOTANIX PHARMACEUTICALS LTD |
|---|---|
| ACN: | 009 109 755 |
| ASX Code: | BOT |
1. Details of substantial holder
Name: Insignia Financial Ltd ACN: 100 103 722
This notice is given by IOOF Holdings Limited on behalf of itself and its subsidiaries.
The holder became a substantial shareholder on: 07/11/2022
2. Previous and present voting power
The total number of votes attached to all the voting shares in the company or voting interest in the scheme that the substantial holder or an associate had a relevant interest in on the date the substantial holder is as follows:
| Class of | Number of | Person's votes | Voting Power |
|---|---|---|---|
| securities | securities | ||
| Ordinary | 70,717,484 | 70,717,484 | 6.117% |
3. Details of present registered holders
The persons registered as holders of the securities are as follows:
| Holder | Registered | Person | Nature of | Class & | Person's |
|---|---|---|---|---|---|
| holder of | Entitle | relevant | Number | votes | |
| securities | d to be | interest | (Ord) | ||
| holder | |||||
| Pursuant to | |||||
| section 608 of | |||||
| Antares Capital Partners Ltd | National | the Corporations | |||
| (ACN 066 081 114) | Nominees (NAS) | Act | 70,717,484 | 70,717,484 |
4. Consideration
The consideration paid for each relevant interest and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:
2
| Date | Person | Nature | Consideration | Class &number(ord) | Person’svotes |
|---|---|---|---|---|---|
| 07/11/2022 | Antares Capital Partners Ltd(ACN 066 081 114) | Placement | 4,455,201.49 | 70,717,484 | 70,717,484 |
5. Associates
| Name & ACN | Nature of association |
|---|---|
| Not applicable |
6. Addresses
The addresses of persons named in this form are as follows:
| Addresses | Addresses | ||
|---|---|---|---|
| . | |||
| he addresses of persons named in this form ar | e as follows: | ||
| N | ame | Address | |
| IO | OF Investment Services Ltd | Level 1, 800 Bourke StreetDocklands VIC 3008 | |
| BOTANIX PHARMACEUTICALS LTD | 68 Aberdeen Street, NorthbridgePERTH, WA 6003, AUSTRALIA | ||
| Antares Capital Partners Ltd | Ground Floor, 105-153 Miller StreetSydney NSW 2000 | ||
| Nulis Nominees (Australia) Ltd | Ground Floor, 105-153 Miller StreetSydney NSW 2000 | ||
| National Nominees (NAS) | Level 1, 800 Bourke StreetDocklands VIC 3008 |